Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

223.31 +2.88 (+1.31%)
Streaming Delayed Price Updated: 3:39 PM EST, Jan 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,450,986
Open 220.51
Bid (Size) 223.26 (400)
Ask (Size) 223.32 (100)
Prev. Close 220.43
Today's Range 219.56 - 223.35
52wk Range 164.39 - 244.81
Shares Outstanding N/A
Dividend Yield 2.94%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Better Long-Term Buy: This Emerging Player or the Industry Leader? ↗
The choice between the two might come down to each investor's goals and risk tolerance. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Q3 Earnings Highs And Lows: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including AbbVie (NYSE:ABBV) and its peers. 
Via StockStory
Topics Artificial Intelligence

Performance

YTD
-2.6%
-2.6%
1 Month
-2.8%
-2.8%
3 Month
-2.1%
-2.1%
6 Month
+18.1%
+18.1%
1 Year
+27.4%
+27.4%

More News

Read More
News headline image
Why AbbVie Stock Trounced the Market in 2025 ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Eli Lilly Reinforces Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences
Via MarketMinute
AbbVie Seeks To Grow Obesity Drug Portfolio — Retail Touts Drugmaker As Big Competition To Lilly ↗
Via Stocktwits
News headline image
Why Revolution Medicines Stock Plummeted by Almost 17% Today ↗
Via The Motley Fool
News headline image
The $6 Billion Disconnect: Why Revolution Medicines (RVMD) Plunged 20% After Merck Talks Collapsed
Via Finterra
Topics Economy Initial Public Offering
News headline image
The Best Dividend Stocks to Buy and Hold Forever ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Economy
News headline image
Viking Therapeutics (VKTX) 2026 Deep Dive: Challenging the Obesity Duopoly
Via Finterra
Topics Intellectual Property
News headline image
2 High-Yielding Dividend Stocks That Retirees Can Rely on for Recurring Income ↗
Via The Motley Fool
Topics Stocks
News headline image
My Top 4 Stocks to Buy in Early 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
The Titan’s Balance: Johnson & Johnson Reaches Record Highs Amidst Legal Hurdles and Med-Tech Transformation
Via MarketMinute
Topics Bankruptcy Lawsuit World Trade
News headline image
1 Safe-and-Steady Stock on Our Watchlist and 2 We Find Risky
Via StockStory
News headline image
The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
3 “Forever Stocks” to Hold When the Market Won’t Sit Still ↗
Via MarketBeat
News headline image
The New Era of Johnson & Johnson: A 2026 Deep-Dive Research Feature
Via Finterra
Topics Artificial Intelligence Bankruptcy Economy
News headline image
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
The Smartest Dividend Stocks to Buy in 2026 With $1,000 Right Now -- Including Realty Income and AbbVie ↗
Via The Motley Fool
News headline image
Could Buying This Stock Today Pay Off Big Over the Next 5 Years? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie Call Options Spike 2,599%: Tracking the Big Bet ↗
Via MarketBeat
News headline image
Genmab Reports Mixed Results From Late-Stage Trial Of Lymphoma Drug ↗
Via Stocktwits
News headline image
3 Absurdly Cheap Growth Stocks to Buy in 2026 ↗
Via The Motley Fool
News headline image
Healthcare Titan Ascendant: Johnson & Johnson Hits All-Time Highs as It Navigates a New Political and Clinical Era
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Earnings
News headline image
Nasdaq, S&P 500 Futures Edge Lower Ahead Of CPI, JPMorgan Earnings: Why MSFT, NVDA, ABBV, ABAT Are Also On Traders' Radar Today ↗
Via Stocktwits
Topics Artificial Intelligence Credit Cards ETFs

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 223.31
When was AbbVie last traded?
The last trade of AbbVie was at 01/30/26 03:39 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.